10 20 30 40 50 60 70 80 1SLA - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER COMPLEX(LECTIN/SACCHARIDE) 12-MAR-94 1SLA
TITLE X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN TITLE 2 (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES
COMPND MOL_ID: 1; COMPND 2 MOLECULE: BOVINE GALECTIN-1; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: COW; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 TISSUE: HEART
KEYWDS COMPLEX(LECTIN-SACCHARIDE), COMPLEX(LECTIN-SACCHARIDE) COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR Y.BOURNE,C.CAMBILLAU
REVDAT 4 13-JUL-11 1SLA 1 VERSN REVDAT 3 25-AUG-09 1SLA 1 SOURCE REVDAT 2 24-FEB-09 1SLA 1 VERSN REVDAT 1 26-JAN-95 1SLA 0
JRNL AUTH Y.BOURNE,B.BOLGIANO,D.I.LIAO,G.STRECKER,P.CANTAU,O.HERZBERG, JRNL AUTH 2 T.FEIZI,C.CAMBILLAU JRNL TITL CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY COMPLEX JRNL TITL 2 BIANTENNARY SACCHARIDES. JRNL REF NAT.STRUCT.BIOL. V. 1 863 1994 JRNL REFN ISSN 1072-8368 JRNL PMID 7773775 JRNL DOI 10.1038/NSB1294-863
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Y.BOURNE,B.BOLGIANO,M.-P.NESA,P.PENFOLD,T.FEIZI,C.CAMBILLAU REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY DIFFRACTION STUDIES OF REMARK 1 TITL 2 THE SOLUBLE 14KDA BETA-GALACTOSIDE-BINDING LECTIN FROM REMARK 1 TITL 3 BOVINE HEART REMARK 1 REF J.MOL.BIOL. V. 235 787 1994 REMARK 1 REFN ISSN 0022-2836
REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 11738 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2056 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 98 REMARK 3 SOLVENT ATOMS : 168 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.46 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1SLA COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 7555 Y,X,-Z REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z REMARK 290 10555 -Y,-X,-Z+1/2 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 59.55000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 59.55000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 59.55000 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 59.55000 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 59.55000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 59.55000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: GALECTIN-1 MOLECULE EXISTS AS A DIMER. IN THE HEXAGONAL REMARK 300 FORM, THERE IS ONE DIMER PRESENT IN THE ASYMMETRIC UNIT. REMARK 300 EACH MONOMER CONSISTS OF 134 AMINO ACID RESIDUES, ASSIGNED REMARK 300 CHAIN IDENTIFIERS A AND B. THE TWO MONOMERS ARE RELATED REMARK 300 BY A NON-CRYSTALLOGRAPHIC TWO-FOLD AXIS. ONE REMARK 300 OLIGOSACCHARIDE UNIT IS PRESENTED PER DIMER. REMARK 300 REMARK 300 THE TRANSFORMATION PRESENTED ON *MTRIX* RECORDS BELOW WILL REMARK 300 YIELD APPROXIMATE COORDINATES FOR CHAIN *B* WHEN APPLIED TO REMARK 300 CHAIN *A*.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD2 ASP B 102 OD2 ASP B 102 7556 2.11 REMARK 500 O HOH A 505 O HOH B 163 11655 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 10 50.99 -140.83 REMARK 500 SER A 29 170.68 179.49 REMARK 500 ASP A 37 -178.16 -173.29 REMARK 500 ASN A 50 80.44 -163.87 REMARK 500 ASN A 56 54.94 38.82 REMARK 500 LYS A 63 100.21 -166.41 REMARK 500 PRO A 78 22.54 -76.22 REMARK 500 ALA A 116 149.17 -171.23 REMARK 500 SER B 29 156.98 163.07 REMARK 500 ASN B 50 90.07 -175.15 REMARK 500 ALA B 116 133.49 -176.79 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 447 DISTANCE = 5.88 ANGSTROMS REMARK 525 HOH A 490 DISTANCE = 5.61 ANGSTROMS REMARK 525 HOH B 181 DISTANCE = 5.39 ANGSTROMS REMARK 525 HOH B 196 DISTANCE = 7.31 ANGSTROMS REMARK 525 HOH B 204 DISTANCE = 5.26 ANGSTROMS
REMARK 600 REMARK 600 HETEROGEN REMARK 600 THE N-ACETYLLACTOSAMINE UNIT LOCATED AT THE EXTREMITY OF REMARK 600 EACH ANTENNA BINDS TO A DIFFERENT MONOMER OF A NEIGHBORING REMARK 600 LECTIN DIMER, THUS FORMING A CHAIN OF CROSS-LINKED LECTIN REMARK 600 SACCHARIDE MOTIFS. SEE JRNL REFERENCE ABOVE.
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: GA1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NULL REMARK 800 REMARK 800 SITE_IDENTIFIER: G1C REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NULL REMARK 800 REMARK 800 SITE_IDENTIFIER: MN1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NULL REMARK 800 REMARK 800 SITE_IDENTIFIER: GA2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NULL REMARK 800 REMARK 800 SITE_IDENTIFIER: GC2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NULL REMARK 800 REMARK 800 SITE_IDENTIFIER: MN2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NULL REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GAL A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAN A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BMA A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAN A 413 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 411 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GAL A 412
DBREF 1SLA A 1 134 UNP P11116 LEG1_BOVIN 1 134 DBREF 1SLA B 1 134 UNP P11116 LEG1_BOVIN 1 134
SEQRES 1 A 134 ALA CYS GLY LEU VAL ALA SER ASN LEU ASN LEU LYS PRO SEQRES 2 A 134 GLY GLU CYS LEU ARG VAL ARG GLY GLU VAL ALA ALA ASP SEQRES 3 A 134 ALA LYS SER PHE LEU LEU ASN LEU GLY LYS ASP ASP ASN SEQRES 4 A 134 ASN LEU CYS LEU HIS PHE ASN PRO ARG PHE ASN ALA HIS SEQRES 5 A 134 GLY ASP VAL ASN THR ILE VAL CYS ASN SER LYS ASP ALA SEQRES 6 A 134 GLY ALA TRP GLY ALA GLU GLN ARG GLU SER ALA PHE PRO SEQRES 7 A 134 PHE GLN PRO GLY SER VAL VAL GLU VAL CYS ILE SER PHE SEQRES 8 A 134 ASN GLN THR ASP LEU THR ILE LYS LEU PRO ASP GLY TYR SEQRES 9 A 134 GLU PHE LYS PHE PRO ASN ARG LEU ASN LEU GLU ALA ILE SEQRES 10 A 134 ASN TYR LEU SER ALA GLY GLY ASP PHE LYS ILE LYS CYS SEQRES 11 A 134 VAL ALA PHE GLU SEQRES 1 B 134 ALA CYS GLY LEU VAL ALA SER ASN LEU ASN LEU LYS PRO SEQRES 2 B 134 GLY GLU CYS LEU ARG VAL ARG GLY GLU VAL ALA ALA ASP SEQRES 3 B 134 ALA LYS SER PHE LEU LEU ASN LEU GLY LYS ASP ASP ASN SEQRES 4 B 134 ASN LEU CYS LEU HIS PHE ASN PRO ARG PHE ASN ALA HIS SEQRES 5 B 134 GLY ASP VAL ASN THR ILE VAL CYS ASN SER LYS ASP ALA SEQRES 6 B 134 GLY ALA TRP GLY ALA GLU GLN ARG GLU SER ALA PHE PRO SEQRES 7 B 134 PHE GLN PRO GLY SER VAL VAL GLU VAL CYS ILE SER PHE SEQRES 8 B 134 ASN GLN THR ASP LEU THR ILE LYS LEU PRO ASP GLY TYR SEQRES 9 B 134 GLU PHE LYS PHE PRO ASN ARG LEU ASN LEU GLU ALA ILE SEQRES 10 B 134 ASN TYR LEU SER ALA GLY GLY ASP PHE LYS ILE LYS CYS SEQRES 11 B 134 VAL ALA PHE GLU
HET NAG A 401 14 HET GAL A 402 11 HET MAN A 403 11 HET BMA A 404 11 HET NAG A 405 15 HET MAN A 413 11 HET NAG A 411 14 HET GAL A 412 11
HETNAM NAG N-ACETYL-D-GLUCOSAMINE HETNAM GAL BETA-D-GALACTOSE HETNAM MAN ALPHA-D-MANNOSE HETNAM BMA BETA-D-MANNOSE
FORMUL 3 NAG 3(C8 H15 N O6) FORMUL 3 GAL 2(C6 H12 O6) FORMUL 3 MAN 2(C6 H12 O6) FORMUL 3 BMA C6 H12 O6 FORMUL 4 HOH *168(H2 O)
SHEET 1 AA 6 VAL A 5 LEU A 11 0 SHEET 2 AA 6 ILE A 117 GLY A 124 -1 SHEET 3 AA 6 PHE A 30 ASP A 37 -1 SHEET 4 AA 6 ASN A 40 ALA A 51 -1 SHEET 5 AA 6 ASP A 54 ASP A 64 -1 SHEET 6 AA 6 ALA A 67 GLU A 74 -1 SHEET 1 AB 5 GLU A 105 PRO A 109 0 SHEET 2 AB 5 ASP A 95 LYS A 99 -1 SHEET 3 AB 5 SER A 83 PHE A 91 -1 SHEET 4 AB 5 LEU A 17 VAL A 23 -1 SHEET 5 AB 5 PHE A 126 ALA A 132 -1 SHEET 1 BA 6 VAL B 5 LEU B 11 0 SHEET 2 BA 6 ILE B 117 GLY B 124 -1 SHEET 3 BA 6 PHE B 30 ASP B 37 -1 SHEET 4 BA 6 ASN B 40 ALA B 51 -1 SHEET 5 BA 6 ASP B 54 ASP B 64 -1 SHEET 6 BA 6 ALA B 67 GLU B 74 -1 SHEET 1 BB 5 GLU B 105 PRO B 109 0 SHEET 2 BB 5 ASP B 95 LYS B 99 -1 SHEET 3 BB 5 SER B 83 PHE B 91 -1 SHEET 4 BB 5 LEU B 17 VAL B 23 -1 SHEET 5 BB 5 PHE B 126 ALA B 132 -1
SSBOND 1 CYS B 16 CYS B 88 1555 1555 2.98
LINK C1 NAG A 401 O2 MAN A 403 1555 1555 1.39 LINK O4 NAG A 401 C1 GAL A 402 1555 1555 1.40 LINK C1 MAN A 403 O3 BMA A 404 1555 1555 1.40 LINK C1 BMA A 404 O4 NAG A 405 1555 1555 1.39 LINK O6 BMA A 404 C1 MAN A 413 1555 1555 1.40 LINK O2 MAN A 413 C1 NAG A 411 1555 1555 1.39 LINK O4 NAG A 411 C1 GAL A 412 1555 1555 1.39
SITE 1 GA1 6 HIS A 44 ASN A 46 ARG A 48 TRP A 68 SITE 2 GA1 6 ASN A 61 GLU A 71 SITE 1 G1C 3 ARG A 48 GLU A 71 ARG A 73 SITE 1 MN1 1 GLY A 53 SITE 1 GA2 6 HIS B 44 ASN B 46 ARG B 48 TRP B 68 SITE 2 GA2 6 ASN B 61 GLU B 71 SITE 1 GC2 3 ARG B 48 GLU B 71 ARG B 73 SITE 1 MN2 1 GLY B 53 SITE 1 AC1 6 ARG A 48 HIS A 52 GLU A 71 ARG A 73 SITE 2 AC1 6 GAL A 402 MAN A 403 SITE 1 AC2 10 HIS A 44 ASN A 46 ARG A 48 HIS A 52 SITE 2 AC2 10 ASN A 61 GLU A 71 NAG A 401 HOH A 429 SITE 3 AC2 10 HOH A 481 HOH A 484 SITE 1 AC3 2 NAG A 401 BMA A 404 SITE 1 AC4 3 MAN A 403 NAG A 405 MAN A 413 SITE 1 AC5 7 ALA A 65 ALA A 67 BMA A 404 HOH A 493 SITE 2 AC5 7 ALA B 51 HIS B 52 GLY B 53 SITE 1 AC6 3 BMA A 404 NAG A 411 HOH B 168 SITE 1 AC7 7 GAL A 412 MAN A 413 HOH A 455 ARG B 48 SITE 2 AC7 7 GLU B 71 ARG B 73 HOH B 166 SITE 1 AC8 10 ASN A 39 NAG A 411 HOH A 424 HIS B 44 SITE 2 AC8 10 ASN B 46 ARG B 48 HIS B 52 ASN B 61 SITE 3 AC8 10 GLU B 71 HOH B 141
CRYST1 106.900 106.900 119.100 90.00 90.00 120.00 P 63 2 2 24
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009355 0.005401 0.000000 0.00000
SCALE2 0.000000 0.010802 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008396 0.00000
MTRIX1 1 0.523890 0.002630 -0.851000 45.30000 1
MTRIX2 1 0.037379 -0.999199 -0.007000 123.80000 1
MTRIX3 1 -0.850900 -0.027600 -0.524000 85.70001 1